22 results
D
LEGN
Legend Biotech Corp
28 Apr 23
$200.00 mm in equity, sold $200.00 mm, 1 investor
4:10pm
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
6-K
EX-99.1
LEGN
Legend Biotech Corp
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
federal health care programs (as defined in 42 U.S.C. §1320a-7b(b)-(f)) or the statutes, regulations and written directives of the FDA, with respect
6-K
EX-1.1
ygvvwa rejyz
27 Jul 22
Announces Pricing of Public Offering
4:35pm
424B5
yc7uzvtht174u
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
5gvp9qmbg
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.4
ry18dsybk45tob3sso
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-1.1
ffwohj
17 Dec 21
Announces Pricing of Public Offering
4:19pm
20-F
ue7e9k0
2 Apr 21
Annual report (foreign)
8:10am
20-F
EX-4.8
rnyaj
2 Apr 21
Annual report (foreign)
8:10am
424B4
wxv1y
8 Jun 20
Prospectus supplement with pricing info
9:07am
F-1/A
u4w1mr
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1/A
EX-1.1
w4e ur3lpqq3
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
EX-10.1
oby1y1otulb
13 May 20
Registration statement (foreign)
4:41pm
F-1
xt5nabs xb25lsd67g6
13 May 20
Registration statement (foreign)
4:41pm
DRS/A
ly0poi2npvnwhw1g9u
8 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
4j50ajby
8 May 20
Draft registration statement (amended)
12:00am